Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3907589rdf:typepubmed:Citationlld:pubmed
pubmed-article:3907589lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:3907589lifeskim:mentionsumls-concept:C0041466lld:lifeskim
pubmed-article:3907589lifeskim:mentionsumls-concept:C0020981lld:lifeskim
pubmed-article:3907589lifeskim:mentionsumls-concept:C0042196lld:lifeskim
pubmed-article:3907589lifeskim:mentionsumls-concept:C0205221lld:lifeskim
pubmed-article:3907589pubmed:issue12lld:pubmed
pubmed-article:3907589pubmed:dateCreated1985-12-23lld:pubmed
pubmed-article:3907589pubmed:abstractTextAngioimmunoblastic lymphadenopathy (AIL) followed typhoid AB vaccination in a patient whose subsequent clinical course was rapidly progressive. At autopsy, extensive lymphadenopathy with features characteristic of AIL and disseminated infection with Escherichia coli, Candida, and Aspergillus were seen. Vaccination is a presumptive precipitating factor in AIL.lld:pubmed
pubmed-article:3907589pubmed:languageenglld:pubmed
pubmed-article:3907589pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3907589pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3907589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3907589pubmed:statusMEDLINElld:pubmed
pubmed-article:3907589pubmed:monthDeclld:pubmed
pubmed-article:3907589pubmed:issn0003-9985lld:pubmed
pubmed-article:3907589pubmed:authorpubmed-author:FIKSlld:pubmed
pubmed-article:3907589pubmed:authorpubmed-author:PhillipsM JMJlld:pubmed
pubmed-article:3907589pubmed:authorpubmed-author:SibbaldR GRGlld:pubmed
pubmed-article:3907589pubmed:authorpubmed-author:EdwardsVVlld:pubmed
pubmed-article:3907589pubmed:issnTypePrintlld:pubmed
pubmed-article:3907589pubmed:volume109lld:pubmed
pubmed-article:3907589pubmed:ownerNLMlld:pubmed
pubmed-article:3907589pubmed:authorsCompleteYlld:pubmed
pubmed-article:3907589pubmed:pagination1085-8lld:pubmed
pubmed-article:3907589pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:meshHeadingpubmed-meshheading:3907589-...lld:pubmed
pubmed-article:3907589pubmed:year1985lld:pubmed
pubmed-article:3907589pubmed:articleTitleAngioimmunoblastic lymphadenopathy following typhoid AB vaccination and terminating in disseminated infection.lld:pubmed
pubmed-article:3907589pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3907589pubmed:publicationTypeCase Reportslld:pubmed